[Atlanta, May 19, 2025] – The global PRRS Vaccine Market, currently valued at USD 1.05 billion, is set for substantial growth, projected to reach USD 1.78 billion by 2031 at a CAGR of 7.8%, according to Clearview Market Insights. This surge is driven by escalating PRRS outbreaks, increasing economic losses in swine herds, and the rising adoption of modern vaccines in high-risk regions.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-porcine-reproductive-respiratory-syndrome-prrs-vaccine-market/

2024 Industry Milestones

Live Vaccine Efficacy Improvements

• Ingelvac PRRS MLV shows enhanced cross-protection in new trials.
• Ceva's thermostable PRRS vaccine gains approval in Southeast Asia.

Next-Gen Vaccine Platforms

• MSD advances recombinant PRRS vaccine to Phase III in Europe.
• Prototype mRNA vaccine demonstrates 90% efficacy in U.S. swine trials.

Regional Expansion and Government Initiatives

• China launches Phase II of its National PRRS Control Program.
• Mexico introduces subsidies for PRRS vaccination in commercial farms.

Executive Insights

PRRS remains the most economically devastating disease in swine. The urgency for broader, faster, and more effective immunization is driving historic innovation,” said Dr. Emma Lawson, Head of Veterinary Research at Clearview Market Insights.

“We are witnessing the birth of the next era in veterinary immunology. PRRS vaccine innovation will set the tone for all future swine disease control efforts,” added Antonio Velez, R&D Director, Ceva Animal Health.

Roadmap to 2031

• 2025: PRRS vaccines included in national veterinary guidelines in 10 new countries.
• 2026: Intranasal PRRS vaccines account for 30% of Asia-Pacific use.
• 2028: First mRNA PRRS vaccine receives commercial approval in North America.
• 2030: Recombinant PRRS vaccines reach 40% market penetration.
• 2031: Integrated AI-vaccine protocols become standard in top 20 global producers.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights

Clearview Market Insights is a global leader in livestock and animal health research. Our experts track more than 100 animal vaccine markets worldwide, helping industry stakeholders make strategic, evidence-based decisions.

 Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369